China Pharmaceuticals Industry Profile - ISIC2423

Beijing Zeefer Consulting Ltd.
September 7, 2013
28 Pages - SKU: BJZ5135798
Colombia Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
Colombia Pharmaceuticals and Healthcare - Report Q4 2014 BMI View: President Juan Manuel Santos' re-election in June has given him a strong mandate to continuethe process of healthcare reform in Colombia. Although the Santos administration has  |  read more...
USD 1,295
Italy Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
Italy Pharmaceuticals and Healthcare - Report Q4 2014 BMI View: The drop in public pharmaceutical expenditure in Italy in 2013 to a level below that of spendinga decade ago does not bode well for prescription drugmakers,  |  read more...
USD 1,295
New Zealand Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
New Zealand Pharmaceuticals and Healthcare - Report Q4 2014 BMI View: Limited pharmaceutical reimbursement in New Zealand will remain a key issue for innovativepharmaceutical firms as the country seeks to maintain tight control over pharmaceutical spending.  |  read more...
USD 1,295
Singapore Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
Singapore Pharmaceuticals and Healthcare - Report Q4 2014 BMI View: While Singapore's small population will limit the pharmaceutical market's overall growthpotential, the government's commitment to healthcare as well as the ageing population will boostconsumption of pharmaceuticals  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Hong Kong Q4 2014
8/27/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare Report - Hong Kong Q4 2014 BMI View: Hong Kong will remain as an attractive destination for foreign pharmaceutical firms due torising medical demands from the ageing population. In addition, its proximity from  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Japan Q4 2014
8/27/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare Report - Japan Q4 2014 BMI View: The weak Japanese yen, coupled with biennial medicine price cuts, will negatively impactmultinational pharmaceutical firms operating in Japan. With effect from April 1 2014, consumption tax  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Namibia Q4 2014
8/27/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare Report - Namibia Q4 2014 BMI View: There are signs the Namibian government is taking the ongoing problem related to drugshortages and supply issues seriously, with the Tender Board of Namibia approving a  |  read more...
USD 1,295
Peru Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
Peru Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: The steadily growing Peruvian pharmaceutical market will provide revenue-earningopportunities for pharmaceutical companies. The country's stringent quality control on imported medicinesis also to the advantage of  |  read more...
USD 1,295
Puerto Rico Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
Puerto Rico Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: Puerto Rico will continue to attract investment from multinational pharmaceutical companiesdue to its tax incentives, relatively low production costs and close ties with the  |  read more...
USD 1,295
Botswana Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
Botswana Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: We remain reasonably optimistic regarding the growth potential of the pharmaceutical andhealthcare markets in Botswana, due to the government's efforts at improving healthcare and developingpharmaceutical  |  read more...
USD 1,295
 

SELECT A LICENSE

    Online Download  USD 580  
    Global Site License  USD 1,450  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!